IMPRINTING DISORDERS: A CLOSER LOOK AT PRADER-WILLI, ANGELMAN, AND BECKWITH-WIEDEMANN SYNDROMES
“๐พ๐๐๐ ๐๐๐ ๐๐๐ก๐ฃ๐๐๐ฅ๐๐๐ ๐๐ค ๐ ๐๐๐๐๐๐๐๐ค๐ ๐๐ช ๐จ๐๐๐๐ ๐ฅ๐๐ ๐ค๐๐๐ ๐๐๐๐ ๐๐๐ ๐๐๐ง๐ ๐๐๐๐๐๐ฅ๐ฃ๐๐๐๐๐๐ช ๐ ๐ก๐ก๐ ๐ค๐๐ฅ๐ ๐๐๐๐๐๐ฅ๐ค ๐๐๐ก๐๐๐๐๐๐ ๐ ๐ ๐จ๐๐๐ฅ๐๐๐ฃ ๐๐ฅ ๐๐ค ๐๐๐๐๐ฃ๐๐ฅ๐๐ ๐๐ฃ๐ ๐ ๐ฅ๐๐ ๐๐ ๐ฅ๐๐๐ฃ ๐ ๐ฃ ๐ฅ๐๐ ๐๐๐ฅ๐๐๐ฃ.” - Prof. Azim Surani
๐งฌ Imprinting disorders arise when genes normally expressed from only one parental allele become dysregulated. This parent-of-origin specific expression is essential for growth, neurodevelopment, and early embryonic programming. When imprinting fails, it results in well-defined syndromes with characteristic features.
Among the most studied are Prader-Willi Syndrome (PWS), Angelman Syndrome (AS), and Beckwith-Wiedemann Syndrome (BWS), each distinct yet unified by a shared epigenetic mechanism.
๐น Prader–Willi Syndrome (PWS): Loss of paternal genes on 15q11–q13 (mainly deletions). Features include infant hypotonia, early feeding issues, later hyperphagia with obesity risk, short stature, cognitive delay, and behavioral problems. Diagnosed by methylation testing; managed with nutritional control, hormone therapy, physiotherapy, and behavioral support.
๐น Angelman Syndrome (AS): Loss of maternal UBE3A function on chromosome 15. Presents with severe developmental delay, lack of speech, ataxia, seizures, and a characteristically joyful affect; obesity is uncommon. Diagnosis via UBE3A genetic testing; management is supportive with speech, motor therapies, seizure control, and educational planning.
๐น Beckwith–Wiedemann Syndrome (BWS): Imprinting defects at 11p15 affecting growth genes (IGF2, H19). Characterized by macrosomia, macroglossia, organomegaly, abdominal wall defects, and increased tumor risk. Diagnosed through clinical scoring and molecular tests; managed with tumor surveillance, nutritional monitoring, and surgical correction.
➡️ Although rooted in impaired genomic imprinting, these syndromes differ markedly:
PWS: paternal allele loss → hyperphagia, behavioral dysregulation
AS: maternal UBE3A loss → neurodevelopmental impairment, characteristic affect
BWS: growth gene dysregulation → overgrowth + tumor predisposition
These contrasts highlight how epigenetic regulation shapes human development.
⚠️ In an Oystershell, imprinting disorders demonstrate the delicate balance of parental gene expression and its developmental consequences. Early diagnosis, genetic counseling, and multidisciplinary care are essential to improving outcomes. Continued research into epigenetic regulation promises future therapeutic strategies for these complex conditions.
Abubakar Abubakar ✍๐ป
• Buiting K. Am J Med Genet C. 2010.
• Bird LM. J Med Genet. 2014.
• Eggermann T et al. Nat Rev Endocrinol. 2014.
• Butler MG. Transl Pediatr. 2017.
• Brioude F et al. Nat Rev Endocrinol. 2018.
#RareDisease #PrecisionMedicine
#BWS #NGS #CRISPR⚕️
Comments
Post a Comment